Pages that link to "Q41137746"
Jump to navigation
Jump to search
The following pages link to A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses (Q41137746):
Displaying 39 items.
- Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party (Q24673195) (← links)
- Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response. (Q30402227) (← links)
- Molecular pathology of allergic disease. II: Upper airway disease (Q33835116) (← links)
- Does allergen immunotherapy alter the natural course of allergic disorders? (Q34212909) (← links)
- Skin prick testing and immunotherapy in nasobronchial allergy: our experience (Q35007608) (← links)
- Molecular immunology and immunotherapy for chronic sinusitis (Q35553429) (← links)
- Safety of rush immunotherapy to multiple aeroallergens in an adult population (Q35754080) (← links)
- Allergen immunotherapy: Review of Efficacy and Current Practice (Q36248980) (← links)
- Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma. (Q37292018) (← links)
- Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review (Q38119883) (← links)
- Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis (Q39455369) (← links)
- Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis (Q40233194) (← links)
- Specific immunotherapy in house dust mite allergy (Q40376122) (← links)
- Immunotherapy for childhood asthma: is there a rationale for its use? (Q40976856) (← links)
- Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challenge (Q41574947) (← links)
- Initial immunological changes as predictors for house dust mite immunotherapy response. (Q42477747) (← links)
- Both allergen-specific CD4 and CD8 Type 2 T cells decreased in asthmatic children with immunotherapy (Q44544977) (← links)
- Mouse allergen exposure and immunologic responses: IgE-mediated mouse sensitization and mouse specific IgG and IgG4 levels (Q44911341) (← links)
- Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis (Q46574562) (← links)
- Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels (Q48020260) (← links)
- Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial (Q51042780) (← links)
- Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy (Q51644402) (← links)
- A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom. (Q52542383) (← links)
- Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. (Q52543970) (← links)
- Subclass profile of allergen-specific IgG antibodies in atopic dogs. (Q52550991) (← links)
- Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. (Q52592976) (← links)
- Allergen immunotherapy: A practice parameter third update (Q52712682) (← links)
- Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy (Q57267014) (← links)
- Allergen-specific Immunotherapy for Allergic Rhinitis: A New Insight into its Clinical Efficacy and Mechanism (Q58169597) (← links)
- A Comparative Study of the Clinical Efficacy of Immunotherapy and Conventional Pharmacological Treatment for Patients with Perennial Allergic Rhinitis (Q58272419) (← links)
- Suplatast Tosilate affects the Initial Increase in Specific IgE and Interleukin-4 during Immunotherapy for Perennial Allergic Rhinitis (Q58278820) (← links)
- A clinical index: A new method to assess efficacy of allergen immunotherapy (Q68210643) (← links)
- Rush immunotherapy: experience with a one-day schedule (Q70987361) (← links)
- Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology (Q72187011) (← links)
- Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long‐term (6‐year) follow‐up (Q73699983) (← links)
- House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study (Q73714861) (← links)
- Effect of Immunotherapy on Serum Levels of Eosinophil Cationic Protein in Perennial Allergic Rhinitis (Q73817276) (← links)
- The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy (Q74590626) (← links)
- Assessment of taste functions in allergic rhinitis patients undergoing allergen-specific immunotherapy (Q90264216) (← links)